中国免疫失调患者大队列体细胞突变图谱
该研究对来自中国41个中心的2912例自身炎症或自身免疫病患者(全外显子测序胚系突变阴性)进行185个免疫相关基因的体细胞突变系统分析,在UBA1、KRAS、NLRP3等基因中鉴定出已知和新发体细胞突变,首次在自身炎症病患者中发现TNFAIP3致病性体细胞突变。成人致病性体细胞突变检出率为1.35%,儿童为0.97%;携带突变的髓系细胞在疾病活动期扩增、缓解期减少,忽视疾病进展中变异等位基因频率的动态升高可导致治疗失败。
要点
- 成人致病性体细胞突变检出率1.35%,儿童0.97%。
- 首次在自身炎症病患者中发现TNFAIP3致病性体细胞突变。
- 携带突变的髓系细胞随疾病活动扩增、缓解减少,动态监测VAF有助避免治疗失败。
核心结论
- 研究描绘了自身炎症和自身免疫病致病性体细胞突变的遗传图谱,为遗传诊断和靶向治疗提供依据。
研究设计与样本
- 对2912例来自中国41个中心的自身炎症或自身免疫病患者,采用185个免疫相关基因panel系统分析体细胞突变;患者此前经全外显子测序均为胚系突变阴性。
主要发现
- 在UBA1、KRAS和NLRP3等基因中鉴定出既往报道的和新发的体细胞突变。
- 首次在自身炎症病患者中发现TNFAIP3致病性体细胞突变。
- 成人致病性体细胞突变检出率为1.35%,儿童为0.97%。
- 在7例患者中鉴定出Ras相关基因体细胞突变,在36例成人患者中鉴定出39个克隆性造血相关突变。
- 携带体细胞突变的髓系细胞在疾病活动期扩增、缓解期减少。
关键数值与推荐
- 致病性体细胞突变检出率:成人1.35%,儿童0.97%。
- Ras相关基因体细胞突变见于7例患者;克隆性造血相关突变39个见于36例成人患者。
临床怎么用
- 对胚系突变阴性的自身炎症或自身免疫病患者,应考虑免疫相关基因panel的体细胞突变检测。
- 疾病进展中应关注变异等位基因频率的动态升高,忽视其变化可导致治疗失败。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to characterize pathogenic somatic mutations in patients with autoinflammatory or autoimmune diseases lacking disease-causing germline mutations, explore their contribution to disease pathogenesis and progression, and evaluate their implications for diagnosis and targeted therapy. METHODS: We performed a systematic analysis of somatic mutations in a selected panel of 185 immune-related genes in 2,912 patients with autoinflammatory or autoimmune diseases, recruited from 41 medical centers across China, who were previously negative for germline mutations based on whole-exome sequencing. RESULTS: We identified both previously reported and novel somatic mutations in genes such as UBA1, KRAS, and NLRP3. Pathogenic somatic mutations in TNFAIP3 were discovered first in patients with autoinflammatory diseases. The pathogenic somatic mutation detection rate was 1.35% in adults and 0.97% in children, emphasizing the importance of genetic diagnosis and novel gene discovery for somatic mutations. In addition, somatic mutations in Ras-related genes were identified in seven patients, and 39 clonal hematopoiesis-associated mutations were identified in 36 adult patients. Moreover, myeloid cells harboring somatic mutations expanded during disease flare and reduced during remission. Disregarding the dynamic elevation of the variant allele fraction during disease progression led to therapeutic failure. CONCLUSION: This study delineated the genetic landscape of pathogenic somatic mutations underlying autoinflammatory and autoimmune diseases, offering valuable insights for genetic diagnosis and targeted therapies.
引用
- Fu J, Fu Q, Wang J, et al. Landscape of Somatic Mutations in a Large Cohort of Chinese Patients With Immune Dysregulations. Arthritis Rheumatol. 2026. PMID: 41801095. doi:10.1002/art.70126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。